Immunotherapy’s “Sweet” Future: Wrapping up AACR IO 2025 With Glyco-immunology
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
Tag: immunotherapy
The final day of AACR IO highlighted the emerging frontier of glyco-immunology.
The third keynote session at AACR IO highlighted exciting advances in CAR T-cell therapy, including for solid cancers.
The second keynote session at AACR IO focused on deciphering T-cell receptors, creating TCR libraries, and rewiring cytokine signaling.
Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night...
This quarterly series on creative approaches to cancer research includes urine-powered nanomotors, unique molds to grow organoids, and more.
Our annual Experts Forecast offers insights from AACR President-Elect Lillian Siu, John E. Dick, Regina Barzilay, Vinod Balachandran, and...
Susan Kaech and Ton Schumacher gave thought-provoking keynotes at the AACR Special Conference in Cancer Research: Tumor Immunology and...
Treating seemingly inoperable liver tumors with neoadjuvant immunotherapy may make surgery more feasible.
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...